Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor

Conclusion
Remission with first-line anti-TNF treatment is an achievable goal in clinical practice, allowing a reduction in concomitant csDMARD and prednisone treatment.

Source: Journal of International Medical Research - September 27, 2016 Category: Research Authors: Conigliaro, P., Chimenti, M. S., Triggianese, P., Ballanti, E., Sunzini, F., Duca, I., Perricone, R. Tags: Real-Life Experiences Source Type: research